Lifelong genetic minipumps

Kathleen M.I. Caron, Leighton R James, Gene Lee, Hyung Suk Kim, Oliver Smithies

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Most physiologists working with animals are familiar with osmotic minipumps. These surgically implanted devices can, for a limited period, administer a reagent at a constant predetermined rate that is unaffected by concurrent procedures. The investigator can then test the physiological effects of other treatments knowing that the animals' homeostatic responses will not be able to alter the dose of the pumped reagent. To develop the genetic equivalent of a lifelong minipump, simply inherited as an autosomal dominant, we here combine three of our previously described strategies, genetic clamping, single-copy chosen-site integration, and modification of untranslated regions (UTRs). As a test of the procedure, we have generated a series of intrinsically useful animals having genetic minipumps secreting renin ectopically from the liver at levels controlled by the investigator but not subject to homeostatic changes. To achieve the different dosage levels of these genetic minipumps, we altered the UTRs of a renin transgene driven by an albumin promoter and inserted it into the genome as a single copy at the ApoA1/ApoC3 locus, a locus that is strongly expressed in the liver. The resulting mice express plasma renin over ranges from near physiological to eightfold wild type and develop graded cardiovascular and kidney disease consequent to their different levels of ectopically secreted renin. The procedure and DNA constructs we describe can be used to generate genetic minipumps for controlling plasma levels of a wide variety of secreted protein products.

Original languageEnglish (US)
Pages (from-to)203-209
Number of pages7
JournalPhysiological Genomics
Volume20
DOIs
StatePublished - Apr 1 2005
Externally publishedYes

Fingerprint

Renin
Untranslated Regions
Research Personnel
Liver
Kidney Diseases
Transgenes
Constriction
Albumins
Cardiovascular Diseases
Genome
Equipment and Supplies
DNA
Proteins

Keywords

  • Gene targeting
  • Hypertension
  • Renin-angiotensin system
  • Transgene

ASJC Scopus subject areas

  • Physiology
  • Genetics

Cite this

Caron, K. M. I., James, L. R., Lee, G., Kim, H. S., & Smithies, O. (2005). Lifelong genetic minipumps. Physiological Genomics, 20, 203-209. https://doi.org/10.1152/physiolgenomics.00221.2004

Lifelong genetic minipumps. / Caron, Kathleen M.I.; James, Leighton R; Lee, Gene; Kim, Hyung Suk; Smithies, Oliver.

In: Physiological Genomics, Vol. 20, 01.04.2005, p. 203-209.

Research output: Contribution to journalArticle

Caron, KMI, James, LR, Lee, G, Kim, HS & Smithies, O 2005, 'Lifelong genetic minipumps', Physiological Genomics, vol. 20, pp. 203-209. https://doi.org/10.1152/physiolgenomics.00221.2004
Caron, Kathleen M.I. ; James, Leighton R ; Lee, Gene ; Kim, Hyung Suk ; Smithies, Oliver. / Lifelong genetic minipumps. In: Physiological Genomics. 2005 ; Vol. 20. pp. 203-209.
@article{a8a479008dbe45a59d41d80a4ad7771f,
title = "Lifelong genetic minipumps",
abstract = "Most physiologists working with animals are familiar with osmotic minipumps. These surgically implanted devices can, for a limited period, administer a reagent at a constant predetermined rate that is unaffected by concurrent procedures. The investigator can then test the physiological effects of other treatments knowing that the animals' homeostatic responses will not be able to alter the dose of the pumped reagent. To develop the genetic equivalent of a lifelong minipump, simply inherited as an autosomal dominant, we here combine three of our previously described strategies, genetic clamping, single-copy chosen-site integration, and modification of untranslated regions (UTRs). As a test of the procedure, we have generated a series of intrinsically useful animals having genetic minipumps secreting renin ectopically from the liver at levels controlled by the investigator but not subject to homeostatic changes. To achieve the different dosage levels of these genetic minipumps, we altered the UTRs of a renin transgene driven by an albumin promoter and inserted it into the genome as a single copy at the ApoA1/ApoC3 locus, a locus that is strongly expressed in the liver. The resulting mice express plasma renin over ranges from near physiological to eightfold wild type and develop graded cardiovascular and kidney disease consequent to their different levels of ectopically secreted renin. The procedure and DNA constructs we describe can be used to generate genetic minipumps for controlling plasma levels of a wide variety of secreted protein products.",
keywords = "Gene targeting, Hypertension, Renin-angiotensin system, Transgene",
author = "Caron, {Kathleen M.I.} and James, {Leighton R} and Gene Lee and Kim, {Hyung Suk} and Oliver Smithies",
year = "2005",
month = "4",
day = "1",
doi = "10.1152/physiolgenomics.00221.2004",
language = "English (US)",
volume = "20",
pages = "203--209",
journal = "Physiological Genomics",
issn = "1094-8341",
publisher = "American Physiological Society",

}

TY - JOUR

T1 - Lifelong genetic minipumps

AU - Caron, Kathleen M.I.

AU - James, Leighton R

AU - Lee, Gene

AU - Kim, Hyung Suk

AU - Smithies, Oliver

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Most physiologists working with animals are familiar with osmotic minipumps. These surgically implanted devices can, for a limited period, administer a reagent at a constant predetermined rate that is unaffected by concurrent procedures. The investigator can then test the physiological effects of other treatments knowing that the animals' homeostatic responses will not be able to alter the dose of the pumped reagent. To develop the genetic equivalent of a lifelong minipump, simply inherited as an autosomal dominant, we here combine three of our previously described strategies, genetic clamping, single-copy chosen-site integration, and modification of untranslated regions (UTRs). As a test of the procedure, we have generated a series of intrinsically useful animals having genetic minipumps secreting renin ectopically from the liver at levels controlled by the investigator but not subject to homeostatic changes. To achieve the different dosage levels of these genetic minipumps, we altered the UTRs of a renin transgene driven by an albumin promoter and inserted it into the genome as a single copy at the ApoA1/ApoC3 locus, a locus that is strongly expressed in the liver. The resulting mice express plasma renin over ranges from near physiological to eightfold wild type and develop graded cardiovascular and kidney disease consequent to their different levels of ectopically secreted renin. The procedure and DNA constructs we describe can be used to generate genetic minipumps for controlling plasma levels of a wide variety of secreted protein products.

AB - Most physiologists working with animals are familiar with osmotic minipumps. These surgically implanted devices can, for a limited period, administer a reagent at a constant predetermined rate that is unaffected by concurrent procedures. The investigator can then test the physiological effects of other treatments knowing that the animals' homeostatic responses will not be able to alter the dose of the pumped reagent. To develop the genetic equivalent of a lifelong minipump, simply inherited as an autosomal dominant, we here combine three of our previously described strategies, genetic clamping, single-copy chosen-site integration, and modification of untranslated regions (UTRs). As a test of the procedure, we have generated a series of intrinsically useful animals having genetic minipumps secreting renin ectopically from the liver at levels controlled by the investigator but not subject to homeostatic changes. To achieve the different dosage levels of these genetic minipumps, we altered the UTRs of a renin transgene driven by an albumin promoter and inserted it into the genome as a single copy at the ApoA1/ApoC3 locus, a locus that is strongly expressed in the liver. The resulting mice express plasma renin over ranges from near physiological to eightfold wild type and develop graded cardiovascular and kidney disease consequent to their different levels of ectopically secreted renin. The procedure and DNA constructs we describe can be used to generate genetic minipumps for controlling plasma levels of a wide variety of secreted protein products.

KW - Gene targeting

KW - Hypertension

KW - Renin-angiotensin system

KW - Transgene

UR - http://www.scopus.com/inward/record.url?scp=15244344236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15244344236&partnerID=8YFLogxK

U2 - 10.1152/physiolgenomics.00221.2004

DO - 10.1152/physiolgenomics.00221.2004

M3 - Article

C2 - 15585607

AN - SCOPUS:15244344236

VL - 20

SP - 203

EP - 209

JO - Physiological Genomics

JF - Physiological Genomics

SN - 1094-8341

ER -